CONVERT PHARMACEUTICALS
Convert Pharmaceuticals is a preclinical stage drug development company, that is building a proprietary drug pipeline exploiting tumor microenvironment specific factors for therapeutic benefit.Convert’s lead product is a hypoxia activated prodrug (HAP). Hypoxia constitutes a therapeutic obstacle as it promotes the development of resistance to conventional anti-cancer treatments. Convert Pharmaceuticals combines proprietary insights in the tumor microenvironment with expertise in drug and biomarker development to develop effective and well-tolerated HAPs.
CONVERT PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Business Development Pharmaceutical
Founded:
2017-01-01
Address:
Liège, Liege, Belgium
Country:
Belgium
Website Url:
http://www.convertpharma.com
Total Employee:
1+
Status:
Active
Contact:
+32 2 880 67 30
Email Addresses:
[email protected]
Total Funding:
13.6 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Apache
Similar Organizations
Ability Pharmaceuticals
Ability Pharmaceuticals is a drug discovery and development company.
Blade Therapeutics
Blade Therapeutics is a discovery stage drug development company.
Exo Therapeutics
Exo Therapeutics is a small molecule drug discovery and development company.
Magpie Pharmaceuticals
Magpie Pharmaceuticals is a biotechnology company.
Silicon Therapeutics
Silicon Therapeutics is a fully integrated drug design, research, and development company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Droia Ventures
Droia Ventures investment in Series A - Convert Pharmaceuticals
Meusinvest (Noshaq)
Meusinvest (Noshaq) investment in Series A - Convert Pharmaceuticals
Eurostars
Eurostars investment in Series A - Convert Pharmaceuticals
Spinventure
Spinventure investment in Series A - Convert Pharmaceuticals
Walloon
Walloon investment in Series A - Convert Pharmaceuticals
Official Site Inspections
http://www.convertpharma.com Semrush global rank: 5.23 M Semrush visits lastest month: 1.56 K
- Host name: 213.193.232.206
- IP address: 213.193.232.206
- Location: Berg en Terblijt Netherlands
- Latitude: 50.8609
- Longitude: 5.7887
- Timezone: Europe/Amsterdam
- Postal: 6325
More informations about "Convert Pharmaceuticals"
Convert Pharmaceuticals Home - Convert …
Convert Pharmaceuticals awarded a prestigious EIC Accelerator grant. Convert Pharmaceuticals, a leader in developing innovative therapies for treatment-resistant cancers, is pleased to announce its recent achievement of being …See details»
About us - Convert Pharmaceuticals
Philippe Lambin is a Clinician, Radiation Oncologist, “ERC advanced & twice ERC PoC grant laureate” respectively from 2016, 2017 & 2020 and pioneer in …See details»
Convert Pharmaceuticals - Crunchbase Company …
Convert Pharmaceuticals is a research and development company. Convert Pharmaceuticals is a clinical phase I-IIa drug development company, that is …See details»
Overview, News & Similar companies - ZoomInfo.com
Feb 27, 2018 Convert Pharmaceuticals contact info: Phone number: +32 28806730 Website: …See details»
Convert Pharmaceuticals - LinkedIn
Convert Pharmaceuticals is a clinical-stage biotech company, developing a proprietary pipeline …See details»
Convert Pharmaceuticals Overview | SignalHire Company Profile
Organization Website: convertpharma.com : Social Links: Phone Number: 32-2-880-67-30: …See details»
Convert Pharmaceuticals - Craft
Convert Pharmaceuticals has 5 employees across 3 locations and $16.61 m in total funding,. …See details»
Convert Pharmaceuticals - Company Profile - Tracxn
Nov 5, 2024 Convert Pharmaceuticals - Developer of small molecule based oncology …See details»
Convert Pharmaceuticals SA - Drug pipelines, Patents, Clinical trials ...
Www.convertpharma.com. Startups | Holding Company | 2017 | Belgium | < 10 | …See details»
Convert Pharmaceuticals awarded a prestigious EIC Accelerator grant
Mar 28, 2024 Convert Pharmaceuticals, a leader in developing innovative therapies for …See details»
Convert Pharmaceuticals Information - RocketReach
What is the NAICS code for Convert Pharmaceuticals? The NAICS codes for Convert …See details»
Convert Pharmaceuticals - VentureRadar
"Convert Pharmaceuticals is a preclinical stage drug development company focused on …See details»
Convert Pharmaceuticals - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Convert …See details»
Convert Pharmaceuticals SA:Company Profile & Technical …
Convert Pharmaceuticals SA is a company that provides Tumor microenvironment, Prodrug, …See details»
Convert Pharmaceuticals - Products, Competitors, Financials, …
External validation of a radiomic signature to predict p16 (HPV) status from standard CT …See details»
Convert Pharmaceuticals | BIO-Europe Spring - Informa Connect
BIO-Europe Spring is the premier springtime partnering conference bringing together a “whoʼs …See details»
Convert Pharmaceuticals - Teams - The Org
Explore 4 teams at Convert Pharmaceuticals. View team members, open roles, and company …See details»
Convert Pharmaceuticals | VentureRadar
Website: http://convertpharma.com/ Convert Pharmaceuticals is a preclinical stage drug …See details»
News Archives - Convert Pharmaceuticals
We are glad to share that the Clinical Trial Application prepared by Convert Pharmaceuticals …See details»
Convert Pharmaceuticals-动脉网 - vbdata.cn
Convert Pharmaceuticals 是一家临床前阶段的药物开发公司，该公司正在构建一条专有药物管 …See details»